Location History:
- Hannover, DE (2013 - 2021)
- Braunschweig, DE (2021 - 2022)
Company Filing History:
2 out of 10 
1 out of 49 
1 out of 1 
Years Active: 2013-2022
Title: The Innovative Mind of Michael Hust: Pioneering Biotechnological Advancements
Introduction
Michael Hust, an accomplished inventor based in Hannover, Germany, has made significant contributions to the field of biotechnology. With a portfolio that includes five patents, his work primarily focuses on therapeutic innovations, particularly in the realms of vaccine development and transplant medicine.
Latest Patents
Among Hust's latest patents is a groundbreaking invention related to compositions and the use of a fibrinogen binding motif present in extracellular fibrinogen binding protein (Efb) and their application in therapeutics and vaccines. This patent outlines methods and compositions that encompass vaccines, monoclonal antibodies, and pharmaceutical compositions designed to deliver targeted agents effectively. His work aims to inhibit fibrinogen binding, enhancing the recognition of Staphylococcus bacterium by phagocytic receptors.
Another notable patent involves a fusion protein designed for the treatment of HvG disease in transplant patients. This innovative fusion protein is engineered to suppress the host's immune response against the transplant, particularly in recipients who lack specific human leukocyte antigen (HLA) expressions. This chimeric antigen receptor (CAR) technology fosters a specific suppressor activity in regulatory T-cells, thereby improving transplant survival rates.
Career Highlights
Michael Hust has had an illustrious career, highlighted by his positions at renowned institutions. He has worked at the Technische Universität Braunschweig, an esteemed research university in Germany, where he furthered his explorations in biomedicine. Additionally, he contributed to projects under the French Ministry of Armed Forces, specifically the Delegation General for Armament, where he utilized his innovative ideas to advance technological applications in defense.
Collaborations
Throughout his career, Hust has collaborated with several prominent figures in the scientific community, including fellow researchers Stefan Dübel and Philippe Thullier. These collaborations have allowed for the exchange of ideas, knowledge, and techniques, significantly enhancing the quality and impact of his innovations in biotechnological research.
Conclusion
Michael Hust's contributions to biotechnology reflect a deep commitment to innovation and the advancement of medical science. His patents not only exhibit his inventive capabilities but also promise significant improvements in therapeutic strategies for various diseases. As he continues to explore new horizons in research, Hust remains a pivotal figure in the intersection of science and healthcare innovation.